In our previous study, we found that brain metastatic cancer cells highly express c-Met, a tyrosine kinase receptor that regulates cell migration, invasion, and survival in breast cancer by activating downstream signaling, including MAPK, STAT, PI3K, and NFκB pathways [7]. Here, MET is linked to breast cancer.